Neurocrine Biosciences, Inc. (0K6R.L)

USD 138.27

(1.59%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.25 Billion 2.36 Billion 2.07 Billion 1.73 Billion 1.3 Billion 993.15 Million
Total Current Assets 1.6 Billion 1.45 Billion 972.8 Million 1.01 Billion 831 Million 737.77 Million
Cash And Short Term Investments 1.03 Billion 989.3 Million 711.3 Million 801 Million 670.5 Million 650.91 Million
Cash and Cash Equivalents 251.1 Million 262.9 Million 340.8 Million 801 Million 112.27 Million 141.71 Million
Short Term Investments 780.5 Million 726.4 Million 370.5 Million 613.9 Million 558.24 Million 509.19 Million
Net Receivables 439.3 Million 350 Million 185.5 Million 157.1 Million 126.57 Million 56.24 Million
Inventory 38.3 Million 35.1 Million 30.5 Million 28 Million 17.28 Million 10.86 Million
Other Current Assets 97.8 Million 464.2 Million 261.5 Million 215.2 Million 160.5 Million 86.86 Million
Total Non-Current Assets 1.64 Billion 915.2 Million 1.09 Billion 718.5 Million 475 Million 255.37 Million
Net PPE 347.3 Million 145.6 Million 155.8 Million 127.4 Million 116.2 Million 33.86 Million
Good Will And Intangible Assets 35.5 Million 37.2 Million - - - -
Good Will 5.8 Million 5.4 Million - - - -
Intangible Assets 35.5 Million 37.2 Million - - - -
Long-Term Investments 849.4 Million 401.5 Million 624.4 Million 265.3 Million 355.6 Million 216.02 Million
Tax Assets 362.6 Million 305.9 Million 315.1 Million 319.4 Million - -
Other Non Current Assets 49.6 Million 25 Million 4.4 Million 6.4 Million 3.2 Million 5.47 Million
Other Assets - - - - - -
Total Liabilities 1.01 Billion 660.9 Million 698.5 Million 608.5 Million 669.1 Million 512.38 Million
Total Current Liabilities 654.8 Million 537.7 Million 245.8 Million 186.5 Million 565.3 Million 88.23 Million
Account Payables 108.9 Million 76.3 Million 51.5 Million 39.4 Million 46.21 Million 13.8 Million
Tax Payables 24.4 Million 9 Million - - - -
Short Term Debt 170.1 Million 169.4 Million 16.5 Million 10.3 Million 408.8 Million 62.34 Million
Deferred Revenue 339.9 Million - -16.5 Million -10.3 Million -46.21 Million 10.23 Million
Other Current Liabilities 35.9 Million 292 Million 194.3 Million 147.1 Million 156.5 Million 1.85 Million
Total Non Current Liabilities 364.6 Million 123.2 Million 452.7 Million 422 Million 103.8 Million 424.15 Million
Long-Term Debt 258.3 Million 93.5 Million 440.4 Million 412.3 Million 86.7 Million 388.49 Million
Deferred Revenue Non Current -78.6 Million -32.79 Million - - - 10.23 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 106.3 Million 29.7 Million 12.3 Million 9.7 Million 17.1 Million 35.65 Million
Other Liabilities - - - - - -
Total Equity 2.23 Billion 1.7 Billion 1.37 Billion 1.12 Billion 636.9 Million 480.76 Million
Stock Holders Equity 2.23 Billion 1.7 Billion 1.37 Billion 1.12 Billion 636.9 Million 480.76 Million
Common Stock 100 Thousand 100 Thousand 100 Thousand 100 Thousand 92 Thousand 91 Thousand
Retained Earnings -157.1 Million -406.8 Million -635.8 Million -725.4 Million -1.13 Billion -1.17 Billion
Accumulated other comprehensive income 7 Million -7.9 Million -1.7 Million 1.8 Million 1.41 Million -1.93 Million
Common Stock Equity 2.23 Billion 1.7 Billion 1.37 Billion 1.12 Billion 636.9 Million 480.76 Million
Capital Lease Obligation 258.3 Million 93.5 Million 105.3 Million 94.4 Million 86.7 Million -
Total Investments 942.4 Million 1.12 Billion 994.9 Million 879.2 Million 913.84 Million 725.22 Million
Total Debt 428.4 Million 262.9 Million 440.4 Million 412.3 Million 495.5 Million 388.49 Million
Net Debt 177.3 Million - 99.6 Million -388.7 Million 383.22 Million 246.78 Million

Balance Sheet Charts